They would get any amount if CAR-Ts were a hot topic in the oncology world, but when googling recent deals, it doesn't look that way. Explains why CHM is struggling as well. Radiotherapy and Radio Imaging is in, Hopper will make his Mozza in that field and can easily write off any personal loss at IMU and CHM. The OV could come to the rescue but as we haven't heard from that front for a long time who knows how good or bad things are in that department. B-Cell? That depends whether that type of vax will have one day its day or whether this is just a dream.
Poor IMU and CHM, once they looked so great.
IMU Price at posting:
2.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)